Review ArticleReviews and Commentaries

Serotonin Syndrome

Jacqueline Volpi-Abadie, Adam M. Kaye and Alan David Kaye
Ochsner Journal December 2013, 13 (4) 533-540;

REFERENCES

  1. ↵
    1. Boyer EW,
    2. Traub SJ,
    3. Grayzel J
    UpToDate, Serotonin syndrome, (Waltham, MA) UpToDate; 2010. Accessed 28 September 2011.
  2. ↵
    1. Boyer EW,
    2. Shannon M
    (3 17, 2005) The serotonin syndrome. N Engl J Med 352(11):1112–1120, pmid:15784664, Erratum in: N Engl J Med. 2007 Jun 7;356(23):2437. N Engl J Med. 2009 Oct 22;361(17):1714.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Dunkley EJ,
    2. Isbister GK,
    3. Sibbritt D,
    4. Dawson AH,
    5. Whyte IM
    (9, 2003) The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 96(9):635–642, pmid:12925718.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Houlihan DJ
    (3, 2004) Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine. Ann Pharmacother 38(3):411–413, pmid:14970364, Epub 2004 Jan 23.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Chander WP,
    2. Singh N,
    3. Mukhiya GK
    (1, 2011) Serotonin syndrome in maintenance haemodialysis patients following sertraline treatment for depression. J Indian Med Assoc 109(1):36–37, pmid:21888157.
    OpenUrlPubMed
  6. ↵
    1. Arora B,
    2. Kannikeswaran N
    (8 20, 2010) The serotonin syndrome - the need for physician's awareness. Int J Emerg Med 3(4):373–377, pmid:21373307.
    OpenUrlPubMed
  7. ↵
    1. Morgan GE,
    2. Mikhail MS,
    3. Murray MJ
    (2006) Clinical Anesthesiology.4th ed (McGraw-Hill; New York, NY).
  8. ↵
    1. Nisijima K,
    2. Yoshino T,
    3. Yui K,
    4. Katoh S
    (1 26, 2001) Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome. Brain Res 890(1):23–31, pmid:11164765.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Dvir Y,
    2. Smallwood P
    (May-Jun 2008) Serotonin syndrome: a complex but easily avoidable condition. Gen Hosp Psychiatry 30(3):284–287, pmid:18433663.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Nisijima K,
    2. Shioda K,
    3. Yoshino T,
    4. Takano K,
    5. Kato S
    (7, 2003) Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome. Neurochem Int 43(2):155–164, pmid:12620284.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Hardman JG,
    2. Limbird LE,
    3. Molinoff PB,
    4. Ruddon RW,
    5. Gilman AG
    (1996) Goodman and Gilman's -The Pharmacological Basis of Therapeutics. 9th ed (McGraw Hill; New York, NY).
  12. ↵
    1. Mitchell PB
    (12, 1997) Drug interactions of clinical significance with selective serotonin reuptake inhibitors. Drug Saf 17(6):390–406, pmid:9429838.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Lange-Asschenfeldt C,
    2. Weigmann H,
    3. Hiemke C,
    4. Mann K
    (8, 2002) Serotonin syndrome as a result of fluoxetine in a patient with tramadol abuse: plasma level-correlated symptomatology. J Clin Psychopharmacol 22(4):440–441, pmid:12172351.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Mason BJ,
    2. Blackburn KH
    (2, 1997) Possible serotonin syndrome associated with tramadol and sertraline coadministration. Ann Pharmacother 31(2):175–177, pmid:9034418.
    OpenUrlPubMed
  15. ↵
    1. Lee J,
    2. Franz L,
    3. Goforth HW
    (Nov-Dec 2009) Serotonin syndrome in a chronic-pain patient receiving concurrent methadone, ciprofloxacin, and venlafaxine. Psychosomatics 50(6):638–639, pmid:19996237.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Levin TT,
    2. Cortes-Ladino A,
    3. Weiss M,
    4. Palomba ML
    (Jul-Aug 2008) Life-threatening serotonin toxicity due to a citalopram-fluconazole drug interaction: case reports and discussion. Gen Hosp Psychiatry 30(4):372–377, pmid:18585543.
    OpenUrlPubMed
  17. ↵
    (2006) Cytochrome P450 drug interactions. Pharmacist's Letter/Prescriber's Letter 22(2), 220233. (Full update October 2009).
  18. ↵
    1. Stanford SC,
    2. Stanford BJ,
    3. Gillman PK
    (10, 2010) Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium. J Psychopharmacol 24(10):1433–1438, pmid:19423610, Epub 2009 May 7.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Isbister GK,
    2. Bowe SJ,
    3. Dawson A,
    4. Whyte IM
    (2004) Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 42(3):277–285, pmid:15362595.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Silins E,
    2. Copeland J,
    3. Dillon P
    (8, 2007) Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk. Aust N Z J Psychiatry 41(8):649–655, pmid:17620161.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Fox MA,
    2. Jensen CL,
    3. Gallagher PS,
    4. Murphy DL
    (10, 2007) Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice. Neuropharmacology 53(5):643–656, pmid:17765930, Epub 2007 Jul 27.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    1. Graudins A,
    2. Stearman A,
    3. Chan B
    (Jul-Aug 1998) Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med 16(4):615–619, pmid:9696181.
    OpenUrlCrossRefPubMed
  23. ↵
    1. McDaniel WW
    (Jul-Aug 2001) Serotonin syndrome: early management with cyproheptadine. Ann Pharmacother 35((7-8)):870–873, pmid:11485136.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Ables AZ,
    2. Nagubilli R
    (5 1, 2010) Prevention, recognition, and management of serotonin syndrome. Am Fam Physician 81(9):1139–1142, pmid:20433130.
    OpenUrlPubMedWeb of Science
  25. ↵
    1. Haslett CD,
    2. Kumar S
    (10, 2002) Can olanzapine be implicated in causing serotonin syndrome? Psychiatry Clin Neurosci 56(5):533–535, pmid:12193243.
    OpenUrlPubMed
  26. ↵
    1. Hamilton S,
    2. Malone K
    (2, 2000) Serotonin syndrome during treatment with paroxetine and risperidone. J Clin Psychopharmacol 20(1):103–105, pmid:10653219.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Boddy R,
    2. Ali R,
    3. Dowsett R
    (2004) Use of sublingual olanzapine in serotonin syndrome [Abstract]. J Toxicol Clin Toxicol 42(5):725.
    OpenUrl
  28. ↵
    1. Nisijima K,
    2. Yoshino T,
    3. Ishiguro T
    (5, 2000) Risperidone counteracts lethality in an animal model of the serotonin syndrome. Psychopharmacology (Berl) 150(1):9–14, pmid:10867971.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords